Bioactivity
ADCdb reports IC50 ~0.10 ng/mL in high-CD33-expressing AML cell lines (e.g., MV4-11) and primary AML samples, rising to >110 ng/mL (up to >5000 ng/mL) in CD33-low/negative lines, indicating CD33 target-dependent cytotoxicity. PBD-dimer payload acts as a DNA minor-groove cross-lin